Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. 2005

M Ito, and S Tanaka, and S Takata, and S Oka, and S Imagawa, and H Ueda, and Y Egi, and Y Kitadai, and W Yasui, and M Yoshihara, and K Haruma, and K Chayama
Department of Medicine and Molecular Science, Hiroshima University, Hiroshima, Japan. maito@hiroshima-u.ac.jp

BACKGROUND It is controversial as to whether the development of gastric cancer is influenced by Helicobacter pylori eradication. If eradication itself influences the tumour morphology, this may affect the tumour discovery rate. OBJECTIVE To investigate the morphological changes in the gastric neoplasm after H. pylori eradication. METHODS We studied 37 patients with eradication therapy. After a 1-month follow-up, endoscopic re-evaluation was performed and the appearance was compared with first image. All lesions were resected endoscopically, and were subjected to histological assessment and to immunohistochemistry. Serum gastrin levels were determined before and after eradication. RESULTS Twenty-nine of 37 patients underwent successful eradication. The appearance of 11 lesions (33% of 33 lesions) became indistinct after successful eradication. All lesions were of the superficial-elevated type and the height of the lesions decreased. We detected normal columnar epithelium over the neoplasm in eight of the lesions. Higher expression of single-stranded deoxyribonucleic acid in the deep area was characteristic in tumours with an indistinct appearance. These changes did not correlate with the serum gastrin levels. CONCLUSIONS The morphology of the gastric neoplasm change after eradication in the short-term. This may contribute to the decreased tumour discovery rate.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005755 Gastrins A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters. Gastrin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Ito, and S Tanaka, and S Takata, and S Oka, and S Imagawa, and H Ueda, and Y Egi, and Y Kitadai, and W Yasui, and M Yoshihara, and K Haruma, and K Chayama
April 2013, Gastrointestinal endoscopy,
M Ito, and S Tanaka, and S Takata, and S Oka, and S Imagawa, and H Ueda, and Y Egi, and Y Kitadai, and W Yasui, and M Yoshihara, and K Haruma, and K Chayama
July 1996, Journal of gastroenterology and hepatology,
M Ito, and S Tanaka, and S Takata, and S Oka, and S Imagawa, and H Ueda, and Y Egi, and Y Kitadai, and W Yasui, and M Yoshihara, and K Haruma, and K Chayama
February 2003, The journal of medical investigation : JMI,
M Ito, and S Tanaka, and S Takata, and S Oka, and S Imagawa, and H Ueda, and Y Egi, and Y Kitadai, and W Yasui, and M Yoshihara, and K Haruma, and K Chayama
November 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M Ito, and S Tanaka, and S Takata, and S Oka, and S Imagawa, and H Ueda, and Y Egi, and Y Kitadai, and W Yasui, and M Yoshihara, and K Haruma, and K Chayama
June 2024, Scientific reports,
M Ito, and S Tanaka, and S Takata, and S Oka, and S Imagawa, and H Ueda, and Y Egi, and Y Kitadai, and W Yasui, and M Yoshihara, and K Haruma, and K Chayama
January 2020, Frontiers in microbiology,
M Ito, and S Tanaka, and S Takata, and S Oka, and S Imagawa, and H Ueda, and Y Egi, and Y Kitadai, and W Yasui, and M Yoshihara, and K Haruma, and K Chayama
August 2021, Journal of gastroenterology and hepatology,
M Ito, and S Tanaka, and S Takata, and S Oka, and S Imagawa, and H Ueda, and Y Egi, and Y Kitadai, and W Yasui, and M Yoshihara, and K Haruma, and K Chayama
November 2013, International journal of cancer,
M Ito, and S Tanaka, and S Takata, and S Oka, and S Imagawa, and H Ueda, and Y Egi, and Y Kitadai, and W Yasui, and M Yoshihara, and K Haruma, and K Chayama
January 1996, The American journal of gastroenterology,
M Ito, and S Tanaka, and S Takata, and S Oka, and S Imagawa, and H Ueda, and Y Egi, and Y Kitadai, and W Yasui, and M Yoshihara, and K Haruma, and K Chayama
February 2014, La Revue du praticien,
Copied contents to your clipboard!